These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6282926)

  • 1. Use of intravenous immune globulin in patients receiving bone marrow transplants.
    Winston DJ; Ho WG; Rasmussen LE; Lin CH; Chu HL; Merigan TC; Gale RP
    J Clin Immunol; 1982 Apr; 2(2 Suppl):42S-47S. PubMed ID: 6282926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation].
    Winston DJ; Ho WG; Lin GH; Bartoni K; Budinger MD; Gale RP; Champlin RE
    Immun Infekt; 1985 Nov; 13(6):296-301. PubMed ID: 3000923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation.
    Winston DJ; Ho WG; Lin CH; Bartoni K; Budinger MD; Gale RP; Champlin RE
    Ann Intern Med; 1987 Jan; 106(1):12-8. PubMed ID: 3024542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation.
    Jacobsen N; Schäfer U; Ostendorf P; Kubaneck B; Wolf H
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):193-5. PubMed ID: 3010510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG; Arvin AM; Koropchak CM; Dobkin MB; Wittek AE; Amylon MD; Budinger MD
    J Pediatr; 1984 Aug; 105(2):200-5. PubMed ID: 6086866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
    Chehimi J; Peppard J; Emanuel D
    Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases].
    Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E
    Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for the occurrence of pneumonia caused by cytomegaloviruses in patients with bone marrow transplants during prevention with cytomegalovirus hyperimmune globulin].
    Schmeiser T; Heit W
    Immun Infekt; 1985 Nov; 13(6):302-6. PubMed ID: 3000924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of anti-CMV antibodies after administration of intravenous immunoglobulins to bone marrow transplant recipients.
    Bosi A; De Majo E; Guidi S; Parri F; Saccardi R; Vannucchi AM; Fanci R; Ferrini PR
    Haematologica; 1990; 75(2):109-12. PubMed ID: 2162799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.
    Schmidt GM; Horak DA; Niland JC; Duncan SR; Forman SJ; Zaia JA
    N Engl J Med; 1991 Apr; 324(15):1005-11. PubMed ID: 1848679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patients.
    Filipovich AH; Peltier MH; Bechtel MK; Dirksen CL; Strauss SA; Englund JA
    Blood; 1992 Nov; 80(10):2656-60. PubMed ID: 1330079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients].
    Bordigoni P; Janot C; Aymard JP; Witz F; Bené MC; Legras B; Schoonemann F; Olive D; Streiff F
    Nouv Rev Fr Hematol (1978); 1987; 29(5):289-93. PubMed ID: 2830588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial.
    Winston DJ; Ho WG; Lin CH; Budinger MD; Champlin RE; Gale RP
    Am J Med; 1984 Mar; 76(3A):128-33. PubMed ID: 6324586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of immunoglobulins and of antibody isotypes in bone marrow transplant recipients treated with high doses of polyspecific immunoglobulin or with cytomegalovirus hyperimmune globulin.
    Gratwohl A; Doran JE; Bachmann P; Scherz R; Späth P; Baumgartner C; Perret B; Berger C; Nissen C; Tichelli A
    Bone Marrow Transplant; 1991 Oct; 8(4):275-82. PubMed ID: 1661632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGIV: a potential role for hepatitis B prophylaxis in the bone marrow peritransplant period.
    Daily J; Werner B; Soiffer R; Fingeroth J
    Bone Marrow Transplant; 1998 Apr; 21(7):739-42. PubMed ID: 9578318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.
    Snydman DR
    Rev Infect Dis; 1990; 12 Suppl 7():S839-48. PubMed ID: 2173113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus immune plasma in bone marrow transplant recipients.
    Winston DJ; Pollard RB; Ho WG; Gallagher JG; Rasmussen LE; Huang SN; Lin CH; Gossett TG; Merigan TC; Gale RP
    Ann Intern Med; 1982 Jul; 97(1):11-8. PubMed ID: 6283982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ; Baume D; Jouet JP
    Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid clearance of cytomegalovirus-specific IgG after repeated intravenous infusions of human immunoglobulin into allogeneic bone marrow transplant recipients.
    Hagenbeek A; Brummelhuis GJ; Donkers A; Dumas AM; ten Haaft A; Schaap BJ; Sizoo W; Löwenberg B
    J Infect Dis; 1987 May; 155(5):897-902. PubMed ID: 3031172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin in bone marrow transplantation.
    Gale RP; Winston D
    Cancer; 1991 Sep; 68(6 Suppl):1451-3. PubMed ID: 1652350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.